{
    "code": "52028152",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=52028152",
    "time": "2022-01-14 04:02:34",
    "許可證字號": "衛部藥輸字第028152號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "115\/09\/08",
    "發證\/登錄日期": "110\/09\/08",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原許可證字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA05202815209",
    "中文品名": "德邁特膜衣錠225毫克",
    "英文品名": "TEPMETKO film-coated Tablets 225 mg",
    "適應症": "適用於治療帶有導致間質上皮轉化因子外顯子14跳讀式突變(MET exon 14 skipping mutation)的轉移性之非小細胞肺癌(NSCLC)成人病人。",
    "劑型": "116膜衣錠",
    "包裝": "4-1000錠鋁箔盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "新成分",
    "監視期限": "115\/09\/08",
    "主成分略述": "Tepotinib Hydrochloride Hydrate",
    "限制項目": "02輸　入 1S須執行確認性療效臨床試驗 5G小兒\/少數嚴重疾病藥品認定",
    "申請商名稱": "1419601100  台灣默克股份有限公司",
    "申請商地址": "台北市內湖區堤頂大道2段89號6樓",
    "主製造廠": [
        {
            "": "GERMANY",
            "製程": ""
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1013009200",
            "成分名稱": "Tepotinib Hydrochloride Hydrate",
            "含量描述": "(equivalent to 225 mg tepotinib)",
            "含量": "250.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "1004-Tepmetko德邁特膜衣錠225mg中文仿單-17.5x87.8cm-110-10-05.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52028152&Seq=001&Type=9"
        },
        {
            "title": "0927-Tepmetko德邁特膜衣錠 225mg 外盒-110-10-05.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52028152&Seq=002&Type=8"
        },
        {
            "title": "0913-Tepmetko德邁特膜衣錠 225mg Foil_PVDC-110-10-05.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52028152&Seq=001&Type=8"
        }
    ]
}